A detailed history of Trustees Of Columbia University In The City Of New York transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 249,635 shares of XLO stock, worth $282,087. This represents 0.29% of its overall portfolio holdings.

Number of Shares
249,635
Previous 249,635 -0.0%
Holding current value
$282,087
Previous $526,000 73.95%
% of portfolio
0.29%
Previous 1.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.97 - $3.03 $491,780 - $756,394
249,635 New
249,635 $672,000

Others Institutions Holding XLO

About Xilio Therapeutics, Inc.


  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $31M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track Trustees Of Columbia University In The City Of New York Portfolio

Follow Trustees Of Columbia University In The City Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Columbia University In The City Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Columbia University In The City Of New York with notifications on news.